CD79A and COVID-19: No significant differences were observed in the anti-E antibody titers across IgM, IgA, and IgG isotypes among the different COVID-19 vaccine platforms (adenovector, mRNA, and protein subunit) in vaccinated individuals (Supplementary Figure S1).